This inventor holds 1 USPTO granted patent. Top assignees: Medivir Ab, Tibotec Pharmaceuticals Ltd.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 120 
1 out of 67 
Years Active: 2012
Title: The Innovations of Bengt Bertril Samuelsson
Introduction: Bengt Bertril Samuelsson, an accomplished inventor based in Skarholmen, Sweden, has made notable contributions to the field of pharmaceuticals. With his groundbreaking patent focusing on hepatitis C virus inhibitors, he has played a significant role in advancing medical research and treatment.
Latest Patents: Samuelsson holds a patent for "Macrocyclic inhibitors of hepatitis C virus - Inhibitors of HCV replication of formula (I)." This invention is critical in the ongoing battle against hepatitis C, showcasing his dedication to improving healthcare through innovation.
Career Highlights: Throughout his career, Samuelsson has worked with esteemed organizations, including Tibotec Pharmaceuticals Ltd. and Medivir AB. His experiences in these companies have bolstered his expertise in drug development and research, enabling him to make impactful advances in the pharmaceutical industry.
Collaborations: Samuelsson has collaborated with prominent colleagues such as Kenneth Simmen and Herman Augustinus De Kock. These partnerships have enhanced the innovation process, combining their diverse skills and knowledge to tackle complex health challenges.
Conclusion: Bengt Bertril Samuelsson's contributions to the pharmaceutical field, highlighted by his significant patent and collaborative work, underline the importance of innovation in addressing global health issues. His dedication continues to inspire future inventors and researchers in the realm of medical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile